Drug Profile
Research programme: CAK-1 inhibitors - Roche
Latest Information Update: 21 Jun 2000
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 21 Jun 2000 Discontinued-Preclinical for Mycoses in Japan (Unknown route)
- 01 Feb 2000 New profile
- 01 Feb 2000 Preclinical development for Mycoses in Japan (Unknown route)